Oxidative modification of HDL by lipid aldehydes impacts HDL function

Area of Science:

• Cardiovascular Science
• Lipid Metabolism
• Oxidative Stress

Background:

• Reduced high-density lipoprotein (HDL) cholesterol is linked to atherosclerotic cardiovascular disease risk.
• HDL's cardioprotective functions include reverse cholesterol transport, inhibiting lipid peroxidation, and suppressing inflammation.
• Clinical trials elevating HDL cholesterol have unexpectedly failed to demonstrate cardioprotection.

Purpose of the Study:

• To review evidence on the discordance between HDL cholesterol levels and HDL function.
• To explore the role of HDL oxidative modification in cardiovascular disease.
• To evaluate the therapeutic potential of dicarbonyl scavengers in protecting HDL function.

Main Methods:

• Review of existing scientific literature and clinical trial data.
• Analysis of mechanisms underlying HDL oxidative modification and dysfunction.
• Examination of preclinical data on dicarbonyl scavengers and atherosclerotic models.

Main Results:

• HDL cholesterol levels and HDL function can be discordant.
• Oxidative modification, particularly by lipid aldehydes, impairs HDL functionality.
• Elevating HDL cholesterol does not guarantee improved cardioprotection if HDL is dysfunctional.
• Dicarbonyl scavengers demonstrate benefit in preclinical models of atherosclerotic cardiovascular disease.

Conclusions:

• HDL's functional capacity, not just its cholesterol level, is critical for cardioprotection.
• Oxidative stress can lead to dysfunctional HDL, negating potential benefits of increased HDL levels.
• Dicarbonyl scavengers represent a potential therapeutic strategy to preserve HDL function and combat atherosclerosis.